-
Aussie Rules fires appeals chair over ruling on anti-gay slur
-
Lakers' OT win puts Rockets on brink of NBA playoff elimination
-
From radiation to invasion: a Chernobyl worker's two wars
-
AI firms flex lobbying muscle on both side of Atlantic
-
First female Archbishop of Canterbury to meet Pope Leo
-
Hundreds of firefighters battle Japan forest blazes
-
Lakers down Rockets in overtime for 3-0 series lead, Celtics hold off Sixers
-
US envoys heading to Pakistan for uncertain Iran talks
-
'Hockey is religion': Montreal fans pack church for playoff push
-
Billionaire Elon Musk enters courtroom showdown with OpenAI
-
Crunch nuclear proliferation meeting at UN amid raging global wars
-
Awkward debut for Trump at correspondents' dinner
-
Under blackout threat, Wikimedia reaches compromise with Indonesia
-
'Going to the moon': Irish footballers return to China 50 years after historic tour
-
Spurs' Wembanyama ruled out of game 3 after concussion
-
Palestinians to vote in first elections since Gaza war
-
Pragmatism, not patriotism, pushes young Lithuanians to military service
-
Peru confirms election runoff date, court says no to Lima re-vote
-
Venezuela, Colombia pledge military cooperation on first post-Maduro visit
-
US hopes for progress, but Iran says not direct talks
-
Maine governor nixes data center moratorium in state
-
Betis's Bellerin further dents Real Madrid title hopes
-
Lens rally but title bid fades after draw at Brest
-
OpenAI CEO apologizes to Canada town for not reporting mass shooter
-
UK PM vows legislation to ban Iran Guards: report
-
Leipzig tighten top-four grip as Union's Eta suffers second loss
-
Furyk named USA captain for 2027 Ryder Cup
-
EU, US sign critical minerals plan to counter China reliance
-
The 'housewives' did well -- Ukraine takes drone know-how abroad
-
Court removes US businessman from managing his Brazilian football team
-
'Natural' birth control risks unwanted pregnancy, experts warn
-
No.2 Korda boosts LPGA Chevron lead to seven
-
EU trade chief seeks 'positive traction' on US steel tariffs
-
Anthropic says Google to pump $40 bn into AI startup
-
Kohli makes Gujarat pay as Bengaluru cruise to IPL win
-
One injured in bomb attack on Colombia military base
-
Envoys from Iran, US expected in Pakistan for new talks
-
ILO names US official as number two amid grumbling over unpaid dues
-
Son of director Rob Reiner pays tribute to slain parents
-
AI united Altman and Musk, then drove them apart
-
Sinner overcomes Bonzi in record hunt at Madrid Open
-
Havana property market stirs as investors bet on political change
-
Children's lives at risk from US funding cuts to vaccine alliance: CEO
-
Brazil's Lula has surgery to remove skin lesion from scalp
-
Defending champion Alcaraz to miss French Open with wrist injury
-
Battle lines drawn over EU's next big budget
-
Renewed hopes of Iran peace talks keep oil under $100 per barrel
-
Lebanon truce extended as Pakistan bids to revive US-Iran talks
-
Assisted dying bill scuppered as UK advocates vow to fight on
-
Alex Marquez quickest in Spanish MotoGP practice
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
Founded in 2019 by industry experts, C2Dx was built on the belief that proven medical devices still have untapped potential to serve patients and providers. Now, as Everis, the company embraces a name that evokes endurance (ever), progress (evolving), and energy (life force)-capturing the spirit of continuous innovation and purpose-driven growth.
"Everis represents who we are becoming," said Sarah Hollingsworth, Vice President of Marketing. "We're not only preserving the legacy of essential technologies-we're building their future. Our new identity reflects our mission to redefine what's possible in patient care."
While the name is new, the company's dedication remains unchanged: providing exceptional customer support, trusted solutions, and a relentless focus on enhancing outcomes.
"Our evolution into Everis reflects more than a name change-it's a signal of our long-term growth trajectory," said Kevin McLeod, CEO. "We're actively building a portfolio of transformative technologies, and we see corporate development as a vital path to scale our impact. Whether through strategic partnerships or acquisitions, we're focused on expansion and growth."
Everis will debut its new branding at COSM 2025, inviting physicians to experience what's next.
For more information, visit everismedical.com.
Media Contact:
Sarah Hollingsworth
Vice President of Marketing
Everis Medical
[email protected]
everismedical.com
SOURCE: Everis
View the original press release on ACCESS Newswire
O.Johnson--AMWN